Research
-
Development of novel antimicrobial therapy for Acanthamoeba Keratitis
Researchers seek to develop novel HDPs with enhanced efficacy and safety to treat Acanthamoeba Keratitis (AK).
CompletedApril 2021 - May 2023 -
The effect of inflammation throughout the body on AMD
Could looking at what’s happening outside the retina in long-term illness shed light on a new approach to treating age-related macular degeneration?
CompletedOctober 2013 - September 2016 -
Making a vital component of gene therapy for retinitis pigmentosa that can be used in clinical trials
Improving on a treatment that works well in animals with a natural form of severe sight loss
CompletedOctober 2013 - September 2016 -
Can a moving target help to make the most of peripheral vision?
Exploring new ideas for visual aids to improve life for people with AMD
CompletedOctober 2013 - September 2016 -
Repairing the retina’s blood supply before sight-threatening damage occurs
Developing a better alternative to anti-VEGF drugs
CompletedDecember 2013 - February 2017 -
How do cell recycling, inflammation and support cell death link together in dry AMD?
Understanding more about a substance that might proect against wet AMD and also cause the dry form.
CompletedOctober 2013 - September 2016 -
Developing a safe 'designer drug' to correct the genetic faults behind inherited eye disorders
A clever approach to treatment that could potentially restore sight
CompletedDecember 2013 - December 2016 -
Can we repair ‘misfolding’ proteins in a common type of retinitis pigmentosa?
Looking for substances that can make the light-detecting pigment rhodopsin more stable.
CompletedOctober 2014 - September 2018 -
Finding more of the genes that cause inherited blindness that starts in childhood
Aiming for an accurate diagnosis for everyone with Leber congenital amaurosis or early onset severe retinal dystrophy
CompletedJanuary 2013 - March 2016